Group 1 - The Hong Kong Stock Connect Innovative Drug ETF managed by Southern Fund (159297) experienced a decline of 1.01% on October 9, with a trading volume of 50.16 million yuan [1] - The fund's shares increased by 6 million, bringing the total shares to 545 million [1] - The latest net asset value of the fund is calculated to be 526 million yuan [1] Group 2 - The performance benchmark for the Hong Kong Stock Connect Innovative Drug ETF is the National Index for Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund has been managed by Southern Fund Management Co., Ltd., with fund managers Zhang Qisi and Ye Zhenan [1] - Since its establishment on September 12, 2025, the fund has reported a return of -3.49% [1]
10月9日港股通创新药ETF南方（159297）份额增加600.00万份
Xin Lang Cai Jing·2025-10-10 01:09